Efficacy and Safety of Ingavirin®, 90 mg Capsules in Patients With COVID-19
Clinical trial NCT05216497 · COMPLETED
Trial details
- NCT number
- NCT05216497
- Sponsor
- Valenta Pharm JSC
- Status
- COMPLETED
- Phase
- Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2021-10-06
- Primary completion
- 2022-01-12
- Enrollment
- 233
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.